#China #Shanghai #NASDAQ #Share Consolidation #Zhongchao

Zhongchao Inc. Announces 1-for-2 Share Consolidation

On September 30, 2026, Zhongchao Inc., a prominent internet technology firm specializing in patient services for major diseases, revealed that it will implement a 1-for-2 share consolidation of its ordinary shares. The consolidation, which has been approved by shareholders and the company's board, is slated to take effect as trading opens on October 2, 2026. This strategic measure is aimed at ensuring the continuous listing of Zhongchao’s shares on the Nasdaq Capital Market, maintaining investor confidence and enhancing market performance.

Objective of the Share Consolidation

The primary purpose of the share consolidation is to consolidate two shares with a par value of $0.744 into one share with a new par value of $0.00001. Consequently, the company will see a reduction in the number of its shares from approximately 8,666,755 Class A ordinary shares and 206,721 Class B ordinary shares to about 4,333,378 Class A and 103,361 Class B shares, respectively. The consolidation will not result in fractional shares being issued; instead, any fraction of a share will be rounded up to the nearest whole number. Such actions are designed to simplify the capital structure and could potentially elevate share prices by reducing the total share count.

Historical Context

Zhongchao has been operational through its platform that offers critical online services related to oncology and other significant health conditions. The company facilitates various professional training and educational services, showcasing its commitment to improving healthcare delivery through advanced technology. The consolidation decision aligns with the company’s broader strategy to enhance its operational stature in the fast-evolving healthcare technology space.

With healthcare technology becoming increasingly critical, especially in the context of rising medical challenges globally, Zhongchao's services are more relevant than ever. Many investors view share consolidation as a positive move since it can signal organizational strength and stability as well as the potential for future growth.

Shareholder Approval and Regulatory Compliance

The decision to consolidate shares received overwhelming support from the company’s shareholders on September 18, 2026, followed by an approval from the board of directors on September 10, 2026. Zhongchao Inc. is committed to remaining compliant with Nasdaq listing requirements, thus ensuring that it retains its status and can continue providing essential services to patients and healthcare providers alike.

Looking Ahead

As the consolidation takes effect, the market will be watching closely to see how this adjustment influences Zhongchao’s stock performance. The company has indicated that this move could bolster its market valuation and receptivity among investors. The consolidation reflects an industry trend where firms are focusing on maximizing shareholder value and creating a more efficient capital structure.

In conclusion, Zhongchao Inc. is taking proactive measures to position itself favorably in the healthcare technology market. As the company moves forward, they will continue to focus on enhancing their service offerings while striving for robust growth in the coming years. For updates and more information about Zhongchao, investors can visit their official investor relations website.